TY  - JOUR

T1  - Guiding pragmatic treatment choices for rifampicin-resistant tuberculosis in the absence of second-line drug susceptibility testing

JO  - European Respiratory Journal

UR  - http://dx.doi.org/10.1183/13993003.00969-2023

PY  - 2023/11/09

AU  - Achar J

AU  - Seddon JA

AU  - Knight GM

AU  - Dodd PJ

AU  - Esmail H

AU  - Hughes J

AU  - McQuaid CF

ED  - 

DO  - DOI: 10.1183/13993003.00969-2023

PB  - European Respiratory Society (ERS)

VL  - 62

IS  - 5

SP  - 2300969

EP  - 2300969

Y2  - 2024/10/23

ER  -